Evidence map›Paper›PMID 34095234›Full record

ReviewFrontiers in molecular biosciences2021

NAD

Benjamin Groth, Padmaja Venkatakrishnan, Su-Ju Lin

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in molecular biosciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. ThebioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. NADCells · 2025
    Review
  13. Increasing cellular NADAmerican journal of physiology. Cell physiology · 2025
    Article
  14. Review
  15. Article
  16. Review
  17. The Histone Deacetylases Hst1 and Rpd3 Integrate De Novo NADInternational journal of molecular sciences · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Benjamin GrothDepartment of Microbiology and Molecular Genetics, College of Biological Sciences, University of California, Davis, Davis, CA, United States.
Padmaja VenkatakrishnanDepartment of Microbiology and Molecular Genetics, College of Biological Sciences, University of California, Davis, Davis, CA, United States.
Su-Ju LinDepartment of Microbiology and Molecular Genetics, College of Biological Sciences, University of California, Davis, Davis, CA, United States.
University of California, Davis · US

Funding

Understanding the Regulation of NAD+Homeostasis and SignalingR01GM102297 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LIN, SU-JU · 2012 to 2019
$2.2M
Understanding the Regulation of NAD+ Homeostasis and SignalingR35GM141855 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LIN, SU-JU · 2021 to 2025
$1.9M
NIGMS NIH HHS R01 GM102297NIGMS NIH HHS R35 GM141855
6 · The paper itself

Abstract

Nicotinamide adenine dinucleotide (NAD

Indexed as

budding yeastde novo NAD+ synthesisimmune responseinfectionkynurenine metabolitesquinolinic acidsiutuin

Identifiers

PMID34095234
PMCPMC8171187
OpenAlexW3162068124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.